Related Experiment Video
Updated: May 4, 2026
07:31
A Computerized Functional Skills Assessment and Training Program Targeting Technology Based Everyday Functional Skills
Published on: February 13, 2020
6.8K
Description and preliminary evaluation of a diabetes technology simulation course
Rebecca D Wilson1, Marilyn Bailey, Mary E Boyle
1Division of Education Administration, Mayo Clinic Hospital, Phoenix, Arizona.
Journal of Diabetes Science and Technology
|December 20, 2013
Summary
A diabetes technology simulation course (DTSC) successfully trained internal medicine residents in using continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring systems (CGMS). Residents reported increased familiarity and satisfaction with these essential diabetes management devices.
Area of Science:
- Medical Education
- Endocrinology
- Diabetes Technology
Background:
- Internal medicine residents require training in advanced diabetes management technologies.
- Continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring systems (CGMS) are crucial for modern diabetes care.
- A gap exists in resident education regarding the practical application of CSII and CGMS.
Purpose of the Study:
- To evaluate the effectiveness of a diabetes technology simulation course (DTSC) for internal medicine residents.
- To assess resident familiarity and satisfaction with CSII and CGMS devices after completing the DTSC.
- To provide data on a pilot simulation-based education program for diabetes technology.
Main Methods:
- The DTSC was implemented in a simulation center, including prerequisites, a practicum, and a web-based simulation.
- Participants were internal medicine residents on an outpatient endocrinology rotation.
- Pre- and post-rotation surveys assessed familiarity with CSII and CGMS; satisfaction questionnaires were also administered.
Main Results:
- All 12 residents in the pilot program completed the DTSC.
- Residents reported high satisfaction with the course (mean scores 4.0-4.9/5).
- Significant increases in self-reported familiarity with CSII and CGMS operation were observed post-rotation (p < .01).
Conclusions:
- Simulation-based education effectively increased residents' perceived familiarity with CSII and CGMS.
- The DTSC is a valuable tool for enhancing diabetes technology education in residency programs.
- Further research will explore expanding the DTSC to other healthcare professionals.
Related Concept Videos
01:26Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
01:15Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
01:26Diabetes Mellitus: Introduction
24
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and...
24
01:22Diabetes Mellitus: Overview and Type I Subtype
5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
01:12Type I Diabetes I: Introduction
45
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
45
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
17
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
17